Profile
Stewart Adkins was a Director of Meldex International Plc.
He was Pharmaceutical Analyst and Managing Director of Pharmaceutical Equity Research at Lehman Brothers for 20 years.
Mr. Adkins worked for Eli Lilly.
Former positions of Stewart Adkins
| Companies | Position | End |
|---|---|---|
| MELDEX INTERNATIONAL PLC | Director/Board Member | 2009-01-18 |
Lehman Brothers International (Europe)
 Lehman Brothers International (Europe) Investment Banks/BrokersFinance Lehman Brothers International (Europe) (LBI) is the London-based subsidiary of Lehman Brothers Holdings, Inc. (NYSE: LEH). Established in 1972, LBI provides trading and broking fixed-income financial instruments, money broking, corporate finance and stock broking services. Lehman Brothers was founded in 1850. | Analyst-Equity | 2003-07-08 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Meldex International Plc
 Meldex International Plc Miscellaneous Commercial ServicesCommercial Services Meldex International Plc develops medicines and healthcare products using polymer technologies. The firm has strategic alliances with various global pharmaceutical companies, including Barr Pliva and FMC BioPolymer, Inc. It has additional offices in London, Paris, Milan, Vienna, Berlin and Tampa & Kansas City. The company was founded in 1996 and is located in Cambridge, UK | Commercial Services |
Lehman Brothers International (Europe)
Lehman Brothers International (Europe) Investment Banks/BrokersFinance Lehman Brothers International (Europe) (LBI) is the London-based subsidiary of Lehman Brothers Holdings, Inc. (NYSE: LEH). Established in 1972, LBI provides trading and broking fixed-income financial instruments, money broking, corporate finance and stock broking services. Lehman Brothers was founded in 1850. | Finance |
- Stock Market
- Insiders
- Stewart Adkins
